* Imunon Inc IMNN.OQ IMNN.O is expected to show a fall
in
quarterly revenue when it reports results on May 11.
*
* Refinitiv's mean analyst estimate for Imunon Inc is for a
loss
of 65 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Imunon Inc
is
$16.5, above its last closing price of $1.39.
This summary was machine generated May 9 at 18:31 GMT. All
figures in US dollars unless otherwise stated